Instruction for use: Retafyl

Dosage form: Sustained-release tablets

Active substance: Theophyllinum

ATX

R03DA04 Theophylline

Pharmacological group

Adenosinergic agents

The nosological classification (ICD-10)

G43 Migraine: The pain of migraine; Migraine; hemiplegic migraine; Migraine headache; A migraine attack; Continuous headache; hemicranias

I27 Other forms of cardiopulmonary diseases: Chronic pulmonary heart disease; Hypertension pulmonary circulation; Pulmonary hypertension; Pulmonary heart disease; pulmonary heart disease; Cardio-pulmonary insufficiency; Secondary pulmonary hypertension; Chronic pulmonary heart; Eisenmenger syndrome

I63 Cerebral infarction: ischemic Stroke; Ischemic brain disease; Ischemic stroke; Ischemic stroke and its consequences; Ischemic cerebral stroke; Ischemic cerebrovascular accident; Ischemic brain damage; Ischemic brain damage; ischemic conditions; Cerebral ischemia; Acute hypoxia brain; Acute cerebral ischemia; Acute ischemic cerebrovascular accident; Acute cerebral infarction; Acute ischemic stroke; Acute period of ischemic stroke; Focal cerebral ischemia; Ischemic stroke; recurrent stroke; The syndrome of Morgagni-Adams-Stokes; Chronic cerebral ischemia; cerebrovascular stroke; embolic stroke; Ischemic brain damage

J45 Asthma: Asthma of physical effort; Asthmatic conditions; Bronchial asthma; Bronchial asthma of light course; Bronchial asthma with difficulty in sputum discharge; Bronchial asthma of severe course; Bronchial asthma physical effort; Hypersecretory asthma; The hormone-dependent form of bronchial asthma; Curbing asthma attacks with bronchial asthma; Non-allergic bronchial asthma; Night Asthma; Exacerbation of bronchial asthma; Attack of bronchial asthma; Endogenous forms of asthma; Night attacks of asthma; Cough with bronchial asthma R06 Abnormal breathing: Kussmaul breath; Respiratory disorders of central origin; Tachypnea

Composition and release form

1 tablet of prolonged action contains theophylline anhydrous 200 or 300 mg; In bottles of 30, 100 (200 mg) or 100 (300 mg) pcs., In the box 1 bottle.

Pharmacology

Mode of action - vasodilator, bronchodilator.

Indications of Retafyl

Bronchial asthma, obstructive pulmonary disease, pulmonary hypertension, nocturnal apnea, migraine, cerebrovascular accident.

Contraindications

Hypersensitivity, peptic ulcer of the stomach and duodenum.

Side effects

Dyspeptic disorders, arrhythmia, CNS excitation.

Interaction

Reduces the absorption of phenytoin; Erythromycin and cytomethidine may enhance the effect.

Dosage and Administration

Inside, once, during dinner (optimally - at 20 h). Adults: 1st week - 300 mg per day, then - 450 mg per day (with body weight less than 70 kg) or 600 mg per day (with a body weight of more than 70 kg). Children: 100 mg each (weight up to 20 kg), 150 mg (weight up to 30 kg) and 200 mg (weight up to 40 kg) 2 times a day.

Storage conditions of Retafyl

At room temperature.

Keep out of the reach of children.

Shelf life of the drug Retafyl

3 years.

Do not use after the expiry date printed on the package.